Skip to main content
Rachel Reckner

Rachel Reckner

VP, Marketing & Market Access

Rachel has almost 20 years of commercialization experience in the healthcare industry. She has held sales, market research, and marketing roles on US, Japanese, and Global teams. Rachel was a brand director for a novel basal insulin and a brand leader for Baqsimi (Nasal Glucagon) at Eli Lilly and Company. After leaving Lilly she joined Astra Zeneca to lead their Type 1 diabetes commercialization program. Rachel earned her Bachelor of Arts from the University of Texas at Austin and an MBA from Texas A&M University.